Effectiveness and tolerability of THC:CBD oromucosal spray as add-on measure in patients with severe chronic pain: analysis of 12-week open-label real-world data provided by the German Pain e-Registry

Effectiveness and tolerability of THC:CBD oromucosal spray as add-on measure in patients with severe chronic pain: analysis of 12-week open-label real-world data provided by the German Pain e-Registry

Michael A Ueberall,1 Ute Essner,2 Gerhard HH Mueller-Schwefe31Institute of Neurological Sciences, 90411 Nuernberg, Germany; 2O.Meany Consultancy, 22339 Hamburg, Germany; 3Interdisciplinary Centre for Pain and Palliative Care Medicine, 73033 Goeppingen, GermanyObjective: To evaluate effectiveness, to...

Full description

Bibliographic Details
Main Authors:	Ueberall MA, Essner U, Mueller-Schwefe GHH
Format:	Article
Language:	English
Published:	Dove Medical Press 2019-05-01
Series:	Journal of Pain Research
Subjects:	THC:CBD spray add-on treatment severe chronic pain neuropathic pain phenomenology benefit- risk profile retrospective analysis German Pain e-Registry
Online Access:	https://www.dovepress.com/effectiveness-and-tolerability-of-thccbd-oromucosal-spray-as-add-on-me-peer-reviewed-article-JPR

Similar Items

A Review of Scientific Evidence for THC:CBD Oromucosal Spray (Nabiximols) in the Management of Chronic Pain
by: Überall MA
Published: (2020-02-01)

An observational postmarketing safety registry of patients in the UK, Germany, and Switzerland, who have been prescribed Sativex® (THC:CBD, nabiximols) oromucosal spray
by: Etges T, et al.
Published: (2016-11-01)

Variability of Multiple Sclerosis Spasticity Symptoms in Response to THC:CBD Oromucosal Spray: Tracking Cases through Clinical Scales and Video Recordings
by: Peter Flachenecker, et al.
Published: (2018-07-01)

Cannabis for Neuropathic Pain in Multiple Sclerosis—High Expectations, Poor Data
by: Thorsten Rudroff, et al.
Published: (2019-10-01)

Real world experience of patients with amyotrophic lateral sclerosis (ALS) in the treatment of spasticity using tetrahydrocannabinol:cannabidiol (THC:CBD)
by: Thomas Meyer, et al.
Published: (2019-09-01)

Pharmacokinetic and Safety Evaluation of Various Oral Doses of a Novel 1:20 THC:CBD Cannabis Herbal Extract in Dogs
by: Alan Chicoine, et al.
Published: (2020-09-01)

The Impact of THC and CBD in Schizophrenia: A Systematic Review
by: Saeed Ahmed, et al.
Published: (2021-07-01)

CBD as the New Medicine in the Pain Provider’s Armamentarium
by: Charlie Piermarini, et al.
Published: (2019-03-01)

Cannabidiol for Pain Treatment: Focus on Pharmacology and Mechanism of Action
by: Jakub Mlost, et al.
Published: (2020-11-01)

Consensus recommendations on dosing and administration of medical cannabis to treat chronic pain: results of a modified Delphi process
by: Arun Bhaskar, et al.
Published: (2021-07-01)

Medical Marijuana, CBD and THC
by: Calhoun, McKenzie L.
Published: (2019)

Efficacy and tolerability balance of oxycodone/naloxone and tapentadol in chronic low back pain with a neuropathic component: a blinded end point analysis of randomly selected routine data from 12-week prospective open-label observations
by: Ueberall MA, et al.
Published: (2016-11-01)

A Review on Studies of Marijuana for Alzheimer’s Disease – Focusing on CBD, THC
by: Seok Hee Kim, et al.
Published: (2019-12-01)

Neuropathic Pain Registries Improve Pain Management and Provide More Efficacious Planning of Healthcare Services
by: Athina Vadalouca, et al.
Published: (2020-04-01)

A cannabis oracle? Delphi method not a substitute for randomized controlled trials of cannabinoids as therapeutics
by: Kevin P. Hill, et al.
Published: (2021-07-01)

Central neuropathic pain
by: João Batista Santos Garcia, et al.

Vape shop owners’/managers’ attitudes about CBD, THC, and marijuana legal markets
by: Carla J. Berg, et al.
Published: (2020-12-01)

Prevalence of neuropathic component of pain in a cohort of patients admitted to an Internal Medicine Department for chronic pain
by: Giuseppe Chesi, et al.
Published: (2015-03-01)

Plant-Based Cannabinoids for the Treatment of Chronic Neuropathic Pain
by: Sherelle L. Casey, et al.
Published: (2018-07-01)

The influence of physiotherapy intervention on patients with multiple sclerosis-related spasticity treated with nabiximols (THC:CBD oromucosal spray).
by: Alessandro Enrico Grimaldi, et al.
Published: (2019-01-01)

Prevalence of central and peripheral neuropathic pain in patients attending pain clinics in Spain: factors related to intensity of pain and quality of life
by: Failde I, et al.
Published: (2018-09-01)

Gabapentin for presumed neuropathic ocular pain
by: Raman Michael, et al.
Published: (2020-09-01)

Clinical characteristics of dry eye with ocular neuropathic pain features: comparison according to the types of sensitization based on the Ocular Pain Assessment Survey
by: Jonghwa Kim, et al.
Published: (2020-11-01)

Back pain
by: Iwan Milanow
Published: (2014-09-01)

Botulinum Toxin for the Treatment of Neuropathic Pain
by: JungHyun Park, et al.
Published: (2017-08-01)

The beneficial use of ultramicronized palmitoylethanolamide as add-on therapy to Tapentadol in the treatment of low back pain: a pilot study comparing prospective and retrospective observational arms
by: Maria Beatrice Passavanti, et al.
Published: (2017-12-01)

Adhesion to neuropathic pain treatment
by: Mirlane Guimarães de Melo Cardoso, et al.

Nurse’s knowledge of neuropathic pain
by: Ali Yavuz Karahan, et al.
Published: (2014-08-01)

Endometriosis and pain
by: Guido Orlandini
Published: (2011-03-01)

Characterizing individual painDETECT symptoms by average pain severity
by: Sadosky A, et al.
Published: (2016-07-01)

Orofacial pain: A critical appraisal in management
by: Shatavisa Mukherjee, et al.
Published: (2015-01-01)

Neuropathic pain
by: V. A. Koriachkin, et al.
Published: (2021-06-01)

Ocular Neuropathic Pain: An Overview Focusing on Ocular Surface Pains
by: Ebrahimiadib N, et al.
Published: (2020-09-01)

Cancer Pain Assessment and Classification
by: Augusto Caraceni, et al.
Published: (2019-04-01)

Effect of palmitoylethanolamide on inflammatory and neuropathic pain in rats
by: Tai-Kyung Seol, et al.
Published: (2017-10-01)

Analysis of the pain and neuroinflammation after rats with neuropathic pain receive immunoglobulin intervention
by: Zhi-Sheng Lu1, et al.
Published: (2017-04-01)

Children and Youth Who Use Cannabis for Pain Relief: Benefits, Risks, and Perceptions
by: Woo JJ, et al.
Published: (2020-05-01)

Study of Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) extraction FROM dried oral fluid spots (DOFS) and LC–MS/MS detection
by: Roberta Gorziza, et al.
Published: (2021-07-01)

Tapentadol for neuropathic pain: a review of clinical studies
by: Freo U, et al.
Published: (2019-05-01)

Psychometric validation of the Portuguese version of the Neuropathic Pain Symptoms Inventory
by: de Andrade Daniel, et al.
Published: (2011-11-01)